FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

40849111000001106: Melatonin 2mg modified-release tablets (Kent Pharma (UK) Ltd) 30 tablet 2 x 15 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Sep 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2416691000001110 Melatonin 2mg modified-release tablets (Kent Pharma (UK) Ltd) 30 tablet 2 x 15 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2416701000001110 Melatonin 2mg modified-release tablets (Kent Pharma (UK) Ltd) 30 tablet 2 x 15 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Melatonin 2mg modified-release tablets (Kent Pharma (UK) Ltd) 30 tablet 2 x 15 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets (Kent Pharma (UK) Ltd) 30 tablet 2 x 15 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets (Kent Pharma (UK) Ltd) 30 tablet 2 x 15 tablets Is a Melatonin 2mg modified-release tablets 30 tablet true Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets (Kent Pharma (UK) Ltd) 30 tablet 2 x 15 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets (Kent Pharma (UK) Ltd) 30 tablet 2 x 15 tablets Has AMP Melatonin 2mg modified-release tablets (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets (Kent Pharma (UK) Ltd) 30 tablet 2 x 15 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets (Kent Pharma (UK) Ltd) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets (Kent Pharma (UK) Ltd) 30 tablet 2 x 15 tablets VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets (Kent Pharma (UK) Ltd) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets (Kent Pharma (UK) Ltd) 30 tablet 2 x 15 tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets (Kent Pharma (UK) Ltd) 30 tablet 2 x 15 tablets Has specific active ingredient Melatonin true Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets (Kent Pharma (UK) Ltd) 30 tablet 2 x 15 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets (Kent Pharma (UK) Ltd) 30 tablet 2 x 15 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start